In addition, the FAM83A gene was reported to be amplified in several human cancers, while silencing FAM83A in related cancer cell lines inhibited the activation of the WNT/β-catenin and TGF-β signaling pathways besides reducing tumorigenicity (Zhang et al. 2019; Liu et al. 2020). The gene discussed is TGFB1; the disease is cancer.